VA SAN diego pharmacy service is requesting a sole source procurement from alliancerx walgreens specialty pharmacy
Ended Awarded Last action
- Contract number
- 36C26223F0026
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $132,074
Award facts
- Contract value 100% obligated
- $132,073.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$5,034 | |
| Original award | $137,108 |
About this award
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 (VISN 22) awarded a delivery order valued at $132,073.87 to Otsuka America Pharmaceutical Inc. on October 10, 2022, for specialty pharmaceutical products to be delivered to the VA San Diego Pharmacy Service. The contract was awarded as a sole source procurement under a firm fixed-price arrangement with no set-aside designation, with an ultimate completion date of September 30, 2023. The award falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), reflecting the VA's standard procurement vehicle for pharmaceutical products supplied to VA medical facilities nationwide.
Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, specializes in developing and distributing medications for complex medical conditions, with particular expertise in specialty pharmaceuticals for the VA Healthcare System. The company maintains substantial indefinite delivery vehicles with the VA, including an $83.3 million Blanket Purchase Agreement for Jynarque (tolvaptan), used to treat autosomal dominant polycystic kidney disease and hyponatremia, and a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology products. This delivery order represents one of multiple task orders Otsuka fulfills across multiple VA Integrated Service Networks to support the agency's mission of providing specialized pharmaceutical treatments to veterans throughout the United States.
Quick answers
Who was awarded contract 36C26223F0026?
36C26223F0026 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on October 10, 2022.
How much is contract 36C26223F0026 worth?
The government has obligated $132,074 on 36C26223F0026.
Is contract 36C26223F0026 an order under another contract?
Yes. 36C26223F0026 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26223F0026 competed?
The extent of competition for 36C26223F0026 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award